Association of Dialysate Bicarbonate with Arrhythmia in the Monitoring in Dialysis Study
- PMID: 39480910
- PMCID: PMC11556930
- DOI: 10.34067/KID.0000000000000537
Association of Dialysate Bicarbonate with Arrhythmia in the Monitoring in Dialysis Study
Abstract
Background: Sudden death accounts for approximately 25% of deaths among maintenance hemodialysis patients, occurring more frequently on hemodialysis days. Higher dialysate bicarbonate (DBIC) may predispose to alkalemia and arrhythmogenesis.
Methods: We conducted a 12-month analysis of session-level data from 66 patients with implantable loop recorders. We fit logistic regression and negative binomial mixed-effects regression models to assess the association of DBIC with clinically significant arrhythmia (ventricular tachycardia ≥115 beats per minute [BPM] for at least 30 seconds, bradycardia ≤40 BPM for at least 6 seconds, or asystole for at least 3 seconds) and reviewer confirmed arrhythmia (RCA—implantable loop recorder-identified or patient-marked event for which a manual review of the stored electrocardiogram tracing confirmed the presence of atrial fibrillation, supraventricular tachycardia, sinus tachycardia with rate >130 BPM, ventricular tachycardia, asystole, or bradycardia). Models adjusted for age, sex, race, hemodialysis vintage, vascular access, and prehemodialysis serum bicarbonate and additionally for serum and dialysate potassium levels.
Results: The mean age was 56±12 years, 70% were male, 53% were Black, and 35% were Asian. Fewer RCA episodes were associated with DBIC >35 than 35 mEq/L (incidence rate ratio 0.45 [0.27 to 0.75] and adjusted incident rate ratio 0.54 [0.30 to 0.97]), but the association was not significant when adjusting for serum and dialysate potassium levels (adjusted incident rate ratio, 0.60 [0.32 to 1.11]). Otherwise, no associations between DBIC and arrhythmia were identified.
Conclusions: We observed a lower frequency of RCA with higher DBIC, compared with DBIC of 35 mEql/L, contrary to our original hypothesis, but this association was attenuated in fully adjusted models. Validation of these findings in larger studies is required, with a further need for interventional studies to explore the optimal DBIC concentration.
Keywords: acidosis; cardiovascular; cardiovascular events; dialysis.
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology
Conflict of interest statement
Disclosure forms, as provided by each author, are available with the online version of the article at
Figures


References
-
- United States Renal Data System. End-stage renal disease (ESRD) in the United States CI, incidence, prevalence, patient characteristics, and treatment modalities. USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Health; 2020.
-
- University of California San Francisco, The Kidney Project. Creating a bioartificial kidney as a permanent solution to kidney failure. Statistics. https://pharm.ucsf.edu/kidney/need/statistics.
-
- Epstein M, Roy-Chaudhury P. Arrhythmias and sudden cardiac death in hemodialysis patients. Temporal profile, electrolyte abnormalities, and potential targeted therapies. Nephrol News Issues 2016;30(4):suppl 23–26. PMID: 27254902 - PubMed
MeSH terms
Substances
Grants and funding
- K23 DK127248/DK/NIDDK NIH HHS/United States
- DK 127248/Foundation for the National Institutes of Health, Medtronic, Novartis India, Sanofi Aventis India, Gilead Sciences, NovoNordisk, Amgen, National Institute of Diabetes and Digestive and Kidney Diseases, Satellite Healthcare, Fifth Eye, Lexicon, Foundation for the National Institutes of Health
LinkOut - more resources
Full Text Sources